Clinical Trial: A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO (R) Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469228) titled 'A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO (R) Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris' on March 09.

Brief Summary: To demonstrate the efficacy, therapeutic equivalence and safety of tretinoin gel microsphere, 0.04% (Sun Pharmaceutical Industries, Inc.) and RETIN-A MICRO (R) (tretinoin) gel microsphere, 0.04% (Reference Listed Drug) in the treatment of acne vulgaris.

Study Start Date: Aug. 04, 2025

Study Type: INTERVENTIONAL

Condition: Acne Vulgaris

Intervention: DRUG: Tretinoin Gel Microsphere, 0.04%

The investigational product will be applied topically to the affected areas of the...